Bone mineral density increases with raloxifene in postmenopausal women
Bone mineral density increases with raloxifene in postmenopausal women
Administration of raloxifene at varying doses (30 mg, black dashed line; 60 mg, green line; 150 mg, blue dotted line) resulted in an increase in bone mineral density compared with placebo (black dotted line) in all sites tested over the two-year follow-up period.
Data from: Delmas PD, Bjarnason NH, Mitlak BH, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 1997; 337:1641.
